Short answer
DiaMedica Therapeutics Inc. (DMAC) filed an 8-K current report with the SEC on May 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2026 results for quarter ended March 31, 2026.
DiaMedica Therapeutics Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results for quarter ended March 31, 2026
- Press release attached as Exhibit 99.1 contains the financial results
- Investor focus: quarterly performance details and outlook disclosed in the exhibit
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other DiaMedica Therapeutics Inc. 8-K filings
Get the next DMAC 8-K as it lands
Follow DMAC for push alerts, or ask the research agent what this filing means.